Central to the homeostatic life of cells is the need to coordinate responses to external and internal 40 changes. These processes become even more important in the context of the sustained cell-cell 41
extracellular space. In general, such proteins interact with specific cell membrane receptors to alter 48 membrane protein/domain organization and/or cytoplasmic/organelle and nuclear events and thus cell 49 response. However, communication by secreted proteins is itself limited through the process of diffusion, 50 which for large macromolecules may not be insignificant (10). 51
Over the last quarter century plus, demonstration of signaling from outside to inside cells via 52 protein ligands and receptors has paralleled technical advances in cell culture, protein biochemistry and 53 antibody development. In contrast, other less cumbersome, more diffusible moieties such as nitric oxide 54 (NO), carbon monoxide (CO) and hydrogen sulfide (H 2 S) have been known to engage with proteins for 55 some time. As early as 1891, H 2 S was reported to interact with hemoglobin (2) and by 1925 this 56 interaction was confirmed for NO (1). However, the meaning of these interactions in terms of human 57 health was not apparent until much later, although the deadly consequences of exposure to CO were 58 known as early as the start of the century (7). As small and highly mobile molecules, NO, CO, H 2 S (4), 59
and other recent possible candidates such as ammonia (NH 3 ), methane (CH 4 ) and even hydrogen (H + ) or 60 hydroxyl (OH -), have been classified as gaso-transmitters. As a group, these agents share properties 61 including being gases under physiologically relevant conditions, crossing cell membranes rapidly, being 62 produced biochemically by proteins (excepting hydroxyl radical), and displaying discrete threshold levels 63 of signaling (6). This shift in perspective from toxic agent or pollutant to active and important signaling 64 molecules has promoted an abundance of research. Translational studies have defined roles for these 65 agents in human health and disease, and this has resulted in clinical studies and in some instances new 66 therapies. The first biogas to reach the clinic as a therapeutic was NO, as an inhaled agent for new-born 67 respiratory failure (1995, NCT00005776) . Applications of NO to human disease was initially via 68 surrogates that intersect the NO signaling cascade such as nitroglycerine (3, 9) , nitrite/nitrate (8), blockers 69 of phosphodiesterase activity to increase NO's second messenger guanosine monophosphate (5), and 70 recently the gaso-transmitter NO itself (ClinicalTrials.gov Identifier: NCT01089439, others). Although 71 CO (Identifier: NCT01523548, others) and H 2 S (Identifier: NCT02899364, others) have been applied in a 72 limited number of trials including phase 3 trials (for CO only), it remains to be seen if these and other 73 biogases or their surrogates will become drugs. 74
Gaso-transmitter science is advancing rapidly as a dynamic and evolving area of research. In this 75 issue, AJP-Cell Physiology begins a Theme of Reviews on Gaso-Transmitters. In the first of this series, 76
Dr. Csaba Szabo of the University of Texas Medical Branch provides a comprehensive review of H 2 S 77 (REF 11, Review article in press) . We hope that the series of Reviews will expand awareness in the 78 scientific and medical community of these fascinating molecules and may also stimulate increased cross-79 disciplinary research. We thank the authors for their kind contributions of expert Reviews for this Theme. 
